TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
9 hedge funds and large institutions have $3.03M invested in TIANYIN PHARMACEUTICAL in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
13% more funds holding
Funds holding: 8 → 9 (+1)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
34% less capital invested
Capital invested by funds: $4.57M → $3.03M (-$1.54M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$132K |
| 2 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$30.4K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$24.4K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$15.4K |
Top Sellers
| 1 |
PAM
Pope Asset Management
Memphis,
Tennessee
|
-$2.88M |
| 2 |
SIM
Spark Investment Management
New York
|
-$14.8K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$4.87K |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $2.24M | -$2.88M | -2,872,758 | -56% |
|
|
2
Renaissance Technologies
New York
| $609K | +$132K | +131,400 | +27% |
|
|
VKH
3
Virtu KCG Holdings
New York
| $39K | -$4.87K | -4,858 | -11% |
|
|
4
Citadel Advisors
Miami,
Florida
| $38K | +$24.4K | +24,289 | +164% |
|
|
RCM
5
Rotella Capital Management
Bellevue,
Washington
| $30K | +$30.4K | +30,305 | New |
|
|
SIM
6
Spark Investment Management
New York
| $25K | -$14.8K | -14,800 | -36% |
|
|
RIM
7
Regent Investment Management
Louisville,
Kentucky
| $24K | – | – | – |
|
|
CS
8
Credit Suisse
Zurich,
Switzerland
| $15K | +$15.4K | +15,343 | New |
|
|
BWFA
9
Baltimore-Washington Financial Advisors
Columbia,
Maryland
| $5K | – | – | – |
|
|
U
10
UBS
Zurich,
Switzerland
| – | -$2K | -3,088 | Closed |
|
TPI Hedge Fund Activity: Q1 2014 in Review
9 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q1 2014, worth a combined $3.03M — down 34% from $4.57M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TPI positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $132K. The largest seller was Pope Asset Management, cutting an estimated $2.88M.
- 9 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q1 2014, up from 8 in Q4 2013.
- Funds reported $3.03M of TIANYIN PHARMACEUTICAL stock for Q1 2014, down 34% quarter-over-quarter.
- 2 funds opened new TIANYIN PHARMACEUTICAL positions in Q1 2014 and 1 closed out, a net change of +1 holder.
- The largest TIANYIN PHARMACEUTICAL buyer in Q1 2014 was Renaissance Technologies, an estimated $132K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q1 2014 was Pope Asset Management, an estimated $2.88M sold.
Based on aggregated 13F filings for Q1 2014.